The present study was based on a sub-cohort of 2, 500
individuals who were selected at random from all participants
with blood sample available at baseline of the EPICPotsdam
study population as part of a separate case-cohort
studies on biomarkers and risk of type 2 diabetes and
cardiovascular diseases [30, 31].